GRIFOLS | GRF - Equity Capital And Reserves


GRIFOLS reported EUR5.46B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Alcon AG USD 22.13B 99M Mar/2026
Almirall EUR 1.49B 24.03M Dec/2025
Amadeus IT EUR 4.8B 49.7M Mar/2026
Amarin USD 449.41M 9.87M Mar/2026
argenx SE USD 7.32B 1.23B Dec/2025
AstraZeneca USD 47.33B 1.33B Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Cie Automotive EUR 1.45B 46.93M Dec/2025
Demant DKK 9.84B 446M Dec/2025
Ence Energia y Celulosa EUR 545.2M 48.76M Mar/2026
Essilor EUR 38.89B 1.07B Dec/2025
Ferrovial EUR 7.66B 11M Dec/2025
Fresenius EUR 19.77B 1.14B Dec/2025
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
Genmab DKK 5.85B 96M Dec/2025
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
GRIFOLS EUR 5.46B 171M Mar/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Inditex 18.8B 1.84B Sep/2025
Lakefront Biotherapeutics EUR 3.25B 17.5M Mar/2026
Merck EUR 29.74B 1.15B Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Philips EUR 11.39B 403M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
Smith & Nephew USD 5.54B 331M Dec/2025
UCB EUR 10.87B 1.18B Dec/2025
Viscofan EUR 932.04M 4.41M Mar/2026